[go: up one dir, main page]

PL3617199T3 - Postać krystaliczna i sól 3-(3,5-dichloro-4-hydroksybenzoilo)-1,1-diokso-2,3-dihydro-1,3- benzotiazolu - Google Patents

Postać krystaliczna i sól 3-(3,5-dichloro-4-hydroksybenzoilo)-1,1-diokso-2,3-dihydro-1,3- benzotiazolu

Info

Publication number
PL3617199T3
PL3617199T3 PL18791567.3T PL18791567T PL3617199T3 PL 3617199 T3 PL3617199 T3 PL 3617199T3 PL 18791567 T PL18791567 T PL 18791567T PL 3617199 T3 PL3617199 T3 PL 3617199T3
Authority
PL
Poland
Prior art keywords
hydroxybenzoyl
benzothiazole
dioxo
dichloro
dihydro
Prior art date
Application number
PL18791567.3T
Other languages
English (en)
Inventor
Junichiro Uda
Seiichi Kobashi
Misa HASEGAWA
Original Assignee
Fuji Yakuhin Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=63918527&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL3617199(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fuji Yakuhin Co., Ltd. filed Critical Fuji Yakuhin Co., Ltd.
Publication of PL3617199T3 publication Critical patent/PL3617199T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Cosmetics (AREA)
PL18791567.3T 2017-04-28 2018-04-27 Postać krystaliczna i sól 3-(3,5-dichloro-4-hydroksybenzoilo)-1,1-diokso-2,3-dihydro-1,3- benzotiazolu PL3617199T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2017099334 2017-04-28
PCT/JP2018/017128 WO2018199277A1 (ja) 2017-04-28 2018-04-27 ３－（３，５－ジクロロ－４－ヒドロキシベンゾイル）－１，１－ジオキソ－２，３－ジヒドロ－１，３－ベンゾチアゾールの結晶形及び塩

Publications (1)

Publication Number Publication Date
PL3617199T3 true PL3617199T3 (pl) 2024-01-22

Family

ID=63918527

Family Applications (1)

Application Number Title Priority Date Filing Date
PL18791567.3T PL3617199T3 (pl) 2017-04-28 2018-04-27 Postać krystaliczna i sól 3-(3,5-dichloro-4-hydroksybenzoilo)-1,1-diokso-2,3-dihydro-1,3- benzotiazolu

Country Status (20)

Country Link
US (1) US10752601B2 (pl)
EP (1) EP3617199B1 (pl)
JP (1) JP7132211B2 (pl)
KR (1) KR102597986B1 (pl)
CN (1) CN110914246B (pl)
AU (1) AU2018256993B9 (pl)
BR (1) BR112019018840B1 (pl)
CA (1) CA3055517A1 (pl)
ES (1) ES2958064T3 (pl)
HR (1) HRP20230829T1 (pl)
HU (1) HUE063661T2 (pl)
IL (1) IL269689B (pl)
MX (1) MX393833B (pl)
MY (1) MY185728A (pl)
PH (1) PH12019501982A1 (pl)
PL (1) PL3617199T3 (pl)
SG (1) SG11201909747WA (pl)
TW (1) TWI766986B (pl)
WO (1) WO2018199277A1 (pl)
ZA (1) ZA201905817B (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3159300A1 (en) * 2019-12-09 2021-06-17 Tadashi Inoue Solid pharmaceutical preparation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR051780A1 (es) * 2004-11-29 2007-02-07 Japan Tobacco Inc Compuestos en anillo fusionados que contienen nitrogeno y utilizacion de los mismos
US20080064871A1 (en) * 2006-05-26 2008-03-13 Japan Tobacco Inc. Production Method of Nitrogen-Containing Fused Ring Compounds
US20080305169A1 (en) 2006-05-26 2008-12-11 Japan Tobacco Inc. Pharmaceutical Compositions Comprising Nitrogen-Containing Fused Ring Coumpounds
GB0702458D0 (en) * 2007-02-08 2007-03-21 Astrazeneca Ab Salts 668
JP2011507910A (ja) 2007-12-21 2011-03-10 ユニバーシティー オブ ロチェスター 真核生物の寿命を変更するための方法
JP5325065B2 (ja) * 2009-09-30 2013-10-23 株式会社富士薬品 新規フェノール誘導体

Also Published As

Publication number Publication date
BR112019018840B1 (pt) 2023-12-19
AU2018256993B9 (en) 2023-06-22
ZA201905817B (en) 2021-05-26
WO2018199277A1 (ja) 2018-11-01
JP7132211B2 (ja) 2022-09-06
HUE063661T2 (hu) 2024-01-28
RU2019130977A (ru) 2021-05-28
KR20200002847A (ko) 2020-01-08
AU2018256993B2 (en) 2021-12-02
EP3617199C0 (en) 2023-07-26
IL269689A (pl) 2019-11-28
HRP20230829T1 (hr) 2023-11-10
ES2958064T3 (es) 2024-01-31
EP3617199A4 (en) 2020-11-18
CN110914246A (zh) 2020-03-24
MY185728A (en) 2021-06-01
SG11201909747WA (en) 2019-11-28
KR102597986B1 (ko) 2023-11-02
TW201843145A (zh) 2018-12-16
CA3055517A1 (en) 2018-11-01
EP3617199A1 (en) 2020-03-04
EP3617199A9 (en) 2021-03-17
EP3617199B1 (en) 2023-07-26
IL269689B (en) 2022-07-01
MX393833B (es) 2025-03-24
US10752601B2 (en) 2020-08-25
TWI766986B (zh) 2022-06-11
CN110914246B (zh) 2023-03-10
PH12019501982A1 (en) 2020-12-07
US20190389818A1 (en) 2019-12-26
AU2018256993A1 (en) 2019-10-10
JPWO2018199277A1 (ja) 2020-03-12
RU2019130977A3 (pl) 2021-07-01
MX2019010710A (es) 2019-12-18
BR112019018840A2 (pt) 2020-04-14
NZ756927A (en) 2025-02-28

Similar Documents

Publication Publication Date Title
IL274887B1 (en) Thiazole derivatives kill microorganisms
IL323188A (en) Thiadiazole and 1,2,4-oxadiazole compounds for use as immunomodulators
PL3887360T3 (pl) Mikrobiocydowe pochodne tiazolowe
IL271459A (en) Monitoring a transplant patient with cell-free DNA
ZA201706531B (en) 3-substituted-1,2,4-oxadiazole and thiadiazole compounds as immunomodulators
IL254046A0 (en) Thiadiazole and 1,3,4-oxadiazole compounds for use as immunomodulators
HUE052020T2 (hu) Mikrobiocid tiazol-származékok
ME03422B (me) Jedinjenja dihidrobenzofurana korisna u liječenju dijabetesa i gojaznosti
IL272121A (en) Preparation and methods for the treatment of myopia
PT4077303T (pt) Tiofeno carboxamidas substituídas e derivados das mesmas como microbicidas
IL273896A (en) Crystal forms of 3-disubstituted 1, 2, 4-oxadiazole
IL265298B (en) History of 5-[2-(pyridin-2-ylamino)-3,1-thiazol-5-yl]-3,2,dihydro-1 h -isoindol-1-one and their use as dual inhibitors of phosphatidylinositol 3-kinase delta and gamma
IL257489A (en) N-[2-(2-amino-6,6-disubstituted-4, 4a, 5, 6-tetrahydropyrano [3,4-d][1,3] thiazin-8a (8h)-yl) -1, 3-thiazol-4-yl] amides
IL273237A (en) Novel heterocyclic compounds as MGLUR7 modulators
IL279939A (en) History of thiadiazine
SG11202006144XA (en) Composition for protecting cornea
GB201707207D0 (en) Treatment of type 1 diabetes
HUE068491T2 (hu) Szubsztituált tiofén-karboxamidok és származékaik mint mikrobicidek
ZA201905817B (en) Crystal form and salt of 3-(3,5-dichloro-4-hydroxybenzoyl)-1,1-dioxo-2,3-dihydro-1,3-benzothiazole
PL3212644T3 (pl) Pochodne 2-(1,2,4-triazol-3-ilosulfanylo)-n-1,3,4-tiadiazol-2 -iloacetamidu, które są przydatne w leczeniu cukrzycy
IL257168B (en) Use of 7-carboxybenzo[1,2,3]thiadiazole amides as plant stimulants
EP3592361C0 (fr) Dérivés aminophosphiniques pour la prévention et le traitement de l'inflammation oculaire
SG11201708692WA (en) Salt form, crystal form and intermediate of 1,2,5-thiadiazolidine-1,1-dioxide and preparation method thereof
EP3615001C0 (de) Zellfreie kombination, hydrogelartiges material oder hydrogel sowie verwendungen davon
ZA202000399B (en) Heterocyclylmethylidene derivatives and their use as modulators of mglur5 receptors